angiotensin II AT1 antagonists (TSRL)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameangiotensin II AT1 antagonists (TSRL)
Drug Alias Namesartans (TSRL)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTherapeutic Systems Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherapeutic Systems Research Laboratories
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A